|
| BPR1J-097 Basic information |
Product Name: | BPR1J-097 | Synonyms: | BPR1J-097;4-(4-methylpiperazin-1-yl)-N-(5-(3-(phenylsulfonamido)phenyl)-1H-pyrazol-3-yl)benzamide;N-(3-(3-[(phenylsulfonyl)amino]phenyl)-1H-pyrazol-5-yl)-4-(4-methylpiperazino) benzamide;N-[5-(3-Benzenesulfonamidophenyl)-1H-pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide;Benzamide, 4-(4-methyl-1-piperazinyl)-N-[5-[3-[(phenylsulfonyl)amino]phenyl]-1H-pyrazol-3-yl]-;BPR1J-097 hydrochloride;CS-2356;CS-2096 | CAS: | 1327167-19-0 | MF: | C27H28N6O3S | MW: | 516.61 | EINECS: | | Product Categories: | Inhibitors | Mol File: | 1327167-19-0.mol | |
| BPR1J-097 Chemical Properties |
Melting point | 247-248 °C | density | 1.368±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | solubility | DMSO:10.0(Max Conc. mg/mL);19.36(Max Conc. mM) DMF:30.0(Max Conc. mg/mL);58.07(Max Conc. mM) DMF:PBS (pH 7.2) (1:6):0.14(Max Conc. mg/mL);0.27(Max Conc. mM) | form | A crystalline solid | pka | 8.17±0.10(Predicted) |
| BPR1J-097 Usage And Synthesis |
Uses | BPR1J-097 is a novel potent FLT3 inhibitor. |
| BPR1J-097 Preparation Products And Raw materials |
|